- Trazimera is Pfizer's first therapeutic oncology biosimilar to receive a positive CHMP opinion from the EMA.
- Herceptin brought in $2.5 billion in the US alone in 2016
... read more
... read more
Glaucoma Research Foundation, a national non-profit organization dedicated to finding a cure for glaucoma, today announced a team of neuroscience researchers, led by Adriana Di Polo, PhD, at... read more
ContraFect Corporation (Nasdaq:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-... read more
HitGen Ltd. Announced... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,